Passage Bio

Passage Bio

Biotechnology Research 2005 Market Street 59 employees
Employees
59
Contacts
3
Emails
3
Phones
1

Passage Bio Overview

Headquarters
2005 Market Street
Phone Number
Available in AeroLeads
Website
passagebio.com
Industry
Biotechnology Research
Employees
59
Founded
2017
Funding
154.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Passage Bio

We are a clinical stage genetic medicines company on a mission to improve the lives of patients with neurodegenerative diseases. Our primary focus is the development and advancement of cutting-edge, one-time therapies designed to target the underlying pathology of these conditions. Our lead product candidate, PBFT02, seeks to treat neurodegenerative conditions, including frontotemporal dementia, by elevating progranulin levels to restore lysosomal function and slow disease progression. Our team's unwavering commitment to excellence is the driving force behind our mission to protect patients and their families against loss in neurodegenerative conditions.

Passage Bio Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
1
25.0% coverage

Passage Bio Org Chart

Sample employees and titles
Name Title Contact
Pamela H. Experienced Clinical Operations Head
View
Karl Whitney
Email
Yan G. Ni Gene Therapy Precision
Email Phone
Steve Krausert Vice President, Supply Chain & Planning
Email

Employees by Management Level

Director 6 profiles
Individual contributor 5 profiles
Executive 2 profiles
Senior / Lead 1 profile

Department Contact Coverage

Department Contacts Email Phone
Executive 2 2 1
General 2 2 0
Finance 1 1 0
Operations 1 1 0

Passage Bio Tech Stack

Data / AI 3 profiles
Engineering 1 profile

Compare Similar Companies to Passage Bio